Accelerate Diagnostics to Present at the J.P. Morgan 34th Annual Healthcare Conference on January 12th
05 janv. 2016 16h15 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, President and Chief Executive Officer, is scheduled to present at...
Accelerate Diagnostics Completes $109 Million Offering, Underwriters Exercise in Full Their Option to Purchase Additional Shares
15 déc. 2015 11h29 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced that it completed a public offering of 6,426,471 shares of common stock today at a previously...
Accelerate Diagnostics Announces Pricing of Public Offering of Common Stock
09 déc. 2015 22h46 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Dec. 9, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 5,588,236 shares of its common stock at a...
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
08 déc. 2015 16h01 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Dec. 8, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced that it has commenced an underwritten public offering of $80 million of shares of its common...
Accelerate Diagnostics Reports Positive Results From Pilot Study of Its Investigational ID/AST System and Blood Culture Assay Kit and Initiation of Trial to Support FDA Clearance
02 déc. 2015 05h30 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced positive findings from a multicenter pilot study to evaluate external performance of its ID/AST System and Blood...
Accelerate Diagnostics to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015
01 déc. 2015 17h37 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update at...
Accelerate Diagnostics to Present at the 35th Annual Canaccord Genuity Growth Conference on August 13, 2015
05 août 2015 05h30 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant...
Accelerate Diagnostics Achieves CE-IVD Milestone for ID/AST System and ID/AST Blood Culture Assay
30 juin 2015 23h58 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., June 30, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79 EC and CE Mark of the...
Accelerate Diagnostics Announces New Leadership Appointments
17 avr. 2015 05h00 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 17, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistant...
Accelerate Diagnostics Names Juan Martin as Head of Europe, Middle East and Africa
23 mars 2015 10h49 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., March 23, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistant...